4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-20-030866
Chairman sold 39,391 shares at an average $91.79 ($3,615,680)
- Chairman acquired 39,391 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
El-Hibri Fuad · Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-09 | Exercise or conversion : show line 1 in the form | +20,000 | $26.45 | $529,000 | 1,143,988 | D |
| 2020-11-09 | Sale : show line 2 in the form | −20,000 | $95.26 | $1,905,200 | 1,123,988 | D |
| 2020-11-10 | Exercise or conversion : show line 3 in the form | +19,391 | $26.45 | $512,892 | 1,143,379 | D |
| 2020-11-10 | Sale : show line 4 in the form | −19,391 | $88.21 | $1,710,480 | 1,123,988 | D |
| Open-market sales · 39,391 sh · avg $91.79 · $3,615,680 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-09 | Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) | −20,000 | 19,391 | D |
| 2020-11-10 | Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) | −19,391 | 0 | D |
Loading xslF345X03/doc4.xml…